The FDA Revokes Its Emergency Use Authorization for Hydroxychloroquine
Jun 22, 2020•9 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
So far, no studies have shown that the anti-malarial drug can fight Covid-19, and agency officials say its potential benefits do not outweigh its risks.
Learn about your ad choices: dovetail.prx.org/ad-choices
For the best experience, listen in Metacast app for iOS or Android